Westfield Capital Management
KYNB

Westfield Capital Management’s Kyntra Bio KYNB Stock Holding History

Westfield Capital Management’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-23,659
Closed -$21.9M – 256
2020
Q4 		$21.9M Buy
23,659
+14,331
+154% +$15.1M 0.13% 175
2020
Q3 		$9.59M Buy
+9,328
New +$10M 0.06% 187
2019
Q4 		– Sell
-12,642
Closed -$11.7M – 243
2019
Q3 		$11.7M Buy
12,642
+302
+2% +$332K 0.09% 181
2019
Q2 		$13.9M Buy
+12,340
New +$13.5M 0.1% 189
2018
Q4 		– Sell
-8,383
Closed -$12.7M – 250
2018
Q3 		$12.7M Sell
8,383
-84
-1% -$129K 0.09% 193
2018
Q2 		$13.3M Buy
+8,467
New +$11M 0.1% 200

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Westfield Capital Management's KYNB Position: Q1 2021 in Review

Westfield Capital Management sold out of Kyntra Bio (KYNB) in Q1 2021, closing a stake of 23,659 shares — an estimated $21.9M sold.

Westfield Capital Management first reported a position in KYNB in Q2 2018 and held it in 6 quarters. The position peaked at $21.9M in Q4 2020. 198 funds tracked by Wall St. Rank hold KYNB as of Q1 2021.

  • Westfield Capital Management reported no remaining Kyntra Bio position as of Q1 2021 after selling out during the quarter.
  • Westfield Capital Management sold 23,659 Kyntra Bio shares in Q1 2021, an estimated $21.9M.
  • Westfield Capital Management first reported a position in Kyntra Bio in Q2 2018 and held it in 6 quarters.
  • Westfield Capital Management's Kyntra Bio position peaked at $21.9M in Q4 2020.
  • 198 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2021.

Based on Westfield Capital Management's 13F filing for Q1 2021, filed 14 May 2021.